Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Sargent

Showing results (101-110 of 514) with videos related to

Pageof 52
Sort By:
Journal of Biopharmaceutical Statistics|April 23, 2009
Current issues in oncology drug development, with a focus on Phase II trialsDaniel J Sargent, Jeremy M G Taylor
Seminars in Oncology|August 4, 2011
Statistical considerations for the next generation of clinical trialsWenting Wu, Qian Shi, Daniel J Sargent
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2011
Survival is not a good outcome for randomized trials with effective subsequent therapiesMarc Buyse, Daniel J Sargent, Everardo D Saad
Journal of the American Statistical Association|February 15, 2011
CAUSAL EFFECTS OF TREATMENTS FOR INFORMATIVE MISSING DATA DUE TO PROGRESSION/DEATHKeunbaik Lee, Michael J Daniels, Daniel J Sargent
Palliative & Supportive Care|April 24, 2025
Motivations for choosing "home" as one's preferred place of death: A scoping reviewTaylor D Pike, Matthew J Sargent, Shannon Freeman
Statistics in Medicine|October 4, 2006
An adaptive phase I design for identifying a biologically optimal dose for dual agent drug combinationsSumithra J Mandrekar, Yue Cui, Daniel J Sargent
Clinical Medicine Insights. Oncology|May 24, 2011
Systemic therapy for elderly patients with gastrointestinal cancerJoleen M Hubbard, Axel Grothey, Daniel J Sargent
Journal of Dialysis|January 1, 1976
Theoretical considerations on molecular transport in dialysis and sorbent therapy for uremiaF A Gotch, P C Farrell, J Sargent
Current Medicinal Chemistry|November 25, 2005
Structure/function overview of proteins involved in iron storage and transportPeter J Sargent, Sebastien Farnaud, Robert W Evans
Cancer Investigation|June 24, 2008
Clinical trials of novel and targeted therapies: endpoints, trial design, and analysisVera J Suman, Amylou Dueck, Daniel J Sargent
Pageof 52

Showing results (101-110 of 514) with videos related to

Sort By:
Pageof 52
Journal of Biopharmaceutical Statistics|April 23, 2009
Current issues in oncology drug development, with a focus on Phase II trialsDaniel J Sargent, Jeremy M G Taylor
Seminars in Oncology|August 4, 2011
Statistical considerations for the next generation of clinical trialsWenting Wu, Qian Shi, Daniel J Sargent
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2011
Survival is not a good outcome for randomized trials with effective subsequent therapiesMarc Buyse, Daniel J Sargent, Everardo D Saad
Journal of the American Statistical Association|February 15, 2011
CAUSAL EFFECTS OF TREATMENTS FOR INFORMATIVE MISSING DATA DUE TO PROGRESSION/DEATHKeunbaik Lee, Michael J Daniels, Daniel J Sargent
Palliative & Supportive Care|April 24, 2025
Motivations for choosing "home" as one's preferred place of death: A scoping reviewTaylor D Pike, Matthew J Sargent, Shannon Freeman
Statistics in Medicine|October 4, 2006
An adaptive phase I design for identifying a biologically optimal dose for dual agent drug combinationsSumithra J Mandrekar, Yue Cui, Daniel J Sargent
Clinical Medicine Insights. Oncology|May 24, 2011
Systemic therapy for elderly patients with gastrointestinal cancerJoleen M Hubbard, Axel Grothey, Daniel J Sargent
Journal of Dialysis|January 1, 1976
Theoretical considerations on molecular transport in dialysis and sorbent therapy for uremiaF A Gotch, P C Farrell, J Sargent
Current Medicinal Chemistry|November 25, 2005
Structure/function overview of proteins involved in iron storage and transportPeter J Sargent, Sebastien Farnaud, Robert W Evans
Cancer Investigation|June 24, 2008
Clinical trials of novel and targeted therapies: endpoints, trial design, and analysisVera J Suman, Amylou Dueck, Daniel J Sargent
Pageof 52